Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 426-426
Open Access | Times Cited: 17

Showing 17 citing articles:

Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 15
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction
Neha S. Rawani, Allen W. Chan, Serdar Dursun, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 709-709
Open Access | Times Cited: 11
Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure
Ana Sofia Machado, Miguel Bragança, Maria Augusta Vieira‐Coelho
Drug and Alcohol Dependence (2024) Vol. 263, pp. 111401-111401
Open Access | Times Cited: 5
Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration
Hans‐Gert Bernstein, Markus Nußbaumer, Veronika Vasilevska, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 5
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1977-1977
Open Access | Times Cited: 11
MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment
Bridget Martinez, Philip V. Peplow
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1523-1531
Open Access | Times Cited: 11
Epigenetic Regulation in Schizophrenia: Focus on Methylation and Histone Modifications in Human Studies
N. Delphin, Caitlin E. Aust, Lyn R. Griffiths, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 272-272
Open Access | Times Cited: 4
Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies
Jurga Bernatonienė, Mindaugas Plieskis, Kęstutis Petrikonis
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 352-352
Open Access
Epigenetics factors in schizophrenia: future directions for etiologic and therapeutic study approaches
Haidong Yang, Wenxi Sun, Jin Li, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Psychedelics action and schizophrenia
Marzena Maćkowiak
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1350-1361
Open Access | Times Cited: 10
Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance
Tapan Behl, Ashishkumar Kyada, R Roopashree, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102556-102556
Closed Access | Times Cited: 3
The Role of Neuroglia in the Development and Progression of Schizophrenia
Neha S. Rawani, Allen W. Chan, Kathryn G. Todd, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Epigenome-Wide Studies of Antipsychotics: A Systematic Review and Pathway Meta-Analysis
Thomas Rowbal, Megan Kajy, Kyle J. Burghardt
Epigenomics (2023) Vol. 15, Iss. 20, pp. 1085-1094
Open Access | Times Cited: 2
Associations among plasma markers for N-methyl-d-aspartate receptor hypofunction, redox dysregulation, and insufficient myelination in patients with schizophrenia
Yoshiaki Isomura, Mikiko Ohno, Satoshi Sudo, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30193-e30193
Open Access
Psychopharmacology and Biological Studies of Psychosis
Marcin Siwek, Bernadeta Szewczyk, Adrian Andrzej Chrobak
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 854-854
Open Access | Times Cited: 1
Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery
Luc Zimmer
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 161-172
Closed Access | Times Cited: 1
Associations Among Plasma Markers for N-Methyl-D-Aspartate Receptor Hypofunction, Redox Dysregulation, and Insufficient Myelination in Patients with Schizophrenia
Yoshiaki Isomura, Mikiko Ohno, Satoshi Sudo, et al.
(2023)
Closed Access
Page 1

Scroll to top